Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HaCaT |
Human keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
HaCaT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | Metafectene | publication | N. Motsch et al., PLoS ONE 7(8): e42193, doi:10.1371/journal.pone.0042193 | Link | |||
HaCatT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | S. Sominsky et al., Virology, 2014, 468-470: 510-523, doi.org/10.1016/j.virol.2014.09.007 | Link | |||
HaCatT |
Human epidermal keratinocyte cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | Y.-S. Kim, Poster 222, Active Material:Organic & Natural, iloveweb.kr | Link | |||
hADMC |
Human primary adipose-derived mast cells | Human | immune system | primary cell | plasmid | Metafectene PRO | publication | M. Motaghed et al., J. Immuntherapy of Cancer, 2021, 9(Suppl 2): A1–A1052, doi.org/10.1136/jitc-2021-SITC2021.220 | Link | ||||
hADSC |
Human primary adipose-derived stem cells | Human | other | stem cell | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
hAEC |
Human aortic endothelial cells | Human | vasculature | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
hASMC |
Human arterial smooth muscle cells | Human | vasculature | unknown | siRNA | RNA-Interference | Metafectene SI | publication | M. R. Schroeter et al., Cardiovasc Res, Aug 2013; 99: 555 - 565 | Link | |||
hBCSCs |
Human breast cancer stem cells (from xenografts of human breast cancers) | Human | respiratory system | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | W.-W. Chang et al., Breast Cancer Res., 2013, 15: R39, doi:10.1186/bcr3423 | Link | ||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | Metafectene | publication | A. M. Scherbakov et al., J. of Cellular Biochem., 2012, 113: 2147–2155 | ||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed breast cells | Human | breast | cell line | adherent | plasmid | Metafectene | application note | ![]() |
||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | stem cell | adherent | plasmid | Metafectene | publication | D. Malik et al., PLoSONE, 13(9):e0203614, doi.org/10.1371/journal.pone.0203614 | Link | |||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. J. Lee et al., Mol. Therapy, 2017, 26(3): 845-859, doi.org/10.1016/j.ymthe.2017.12.015 | Link | ||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | stem cell | adherent | siRNA | Metafectene PRO | publication | E. J. Lee, Mol. Therapy, 2018, doi: 10.1016/j.ymthe.2017.12.015 | ||||
hBVP |
Human brain vascular pericytes | Human | brain | unknown | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
hBVP |
Human brain vascular pericytes | Human | brain | unknown | adherent | mRNA | K2 Transfection System | application note | ![]() |
||||
HCC-44 |
Human lung adenocarcinoma cell line | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Berrout et al., Nature Communications, 2017,8: 947, DOI: 10.1038/s41467-017-00983-w | Link | |||
HCC-515 |
Human lung adenocarcinoma cell line | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Berrout et al., Nature Communications, 2017,8: 947, DOI: 10.1038/s41467-017-00983-w | Link | |||
hCMEC/D3 |
Human brain-derived microvascular endothelial cells | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Krishnan et al.,Oncotarget, 2015, 6(26): 22480-22495 | Link | ||
hConEC |
Human primary conjunctival epithel cells | Human | sensory organs | primary cell | adherent | miRNA | Metafectene SI | publication | Q. Pilson et al., Scientific Reports, 2020, 10: 7484, doi.org/10.1038/s41598-020-64422-5 | Link | |||
HCT-116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob-Schwarzl et al., Oncotarget, 2017, 8(60): 101224-101243 | Link |